Cochrane Infectious Diseases Group, UK
The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment of infectious diseases of relevance to the United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases in low- and middle-income countries.
The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high-quality, relevant systematic reviews and to lead developments in review quality improvement and effective dissemination of findings.
- has over 700 active authors from around the world currently preparing or updating Cochrane systematic reviews.
- includes 21 international Editors, Managing Editor, Statistician, Information Specialists, Editorial Assistants, and Specialist Advisors.
- provides training and support for author teams in preparing and updating reviews, and methodological help in all aspects of research synthesis, including preparing 'Summary of findings' tables.
All published CIDG Cochrane protocols, reviews, and updates can be viewed on the Cochrane Library (select the review group 'Infectious Diseases')
Selected CIDG publications
Ivermectin treatment in humans for reducing malaria transmission (June 2021) Read the LSTM news story here.
Probiotics for treating acute infectious diarrhoea (December 2020) Read the LSTM news story here.
Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review (September 2020)
Public health deworming programmes for soil-transmitted helminths in children living in endemic areas (September 2019) Read the LSTM news story here.
Pyronaridine plus artesunate for treating uncomplicated Plasmodium falciparum malaria (January 2019) Read the LSTM news story here.
Insecticide space spraying for preventing malaria transmission (November 2018)
Insecticide‐treated nets for preventing malaria (November 2018)